A pilot, randomised placebo-controlled study of cognitive enhancer and cognitive training combination: testing a therapeutic paradigm for cognitive impairment in schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2015
At a glance
- Drugs Modafinil (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms ModCTCoS
- 01 Dec 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 19 Mar 2012 European Clinical Trials Database record reports planned end date is 23 Mar 2011.
- 23 Feb 2012 Planned end date (1 Dec 2012) added as reported by ISRCTN: Current Controlled Trials.